Open an account

Doximity

DOCS · NYSE

$33.35+$1.90 (+6.04%)TodayMarket closed ·
Prev close $31.45

About DOCS

Doximity, Inc. engages in the development and operation of an online platform for medical professionals. The company is headquartered in San Francisco, California and currently employs 830 full-time employees. The company went IPO on 2021-06-24. The company offers marketing, hiring, and workflow solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and other healthcare companies. Its marketing solutions enable its pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Its hiring solutions provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them to identify, connect with, and hire from its network of both active and passive medical professional candidates, who might otherwise be missed through traditional recruiting channels. Its workflow solutions include its telehealth, on-call scheduling, and AI-powered workflow tools, are designed to help clinicians streamline their clinical workflow, reduce their administrative burden, and connect with patients and colleagues.

Employees
830
Headquarters
San Francisco, California
Listed
Jun 24, 2021
Sector
Health Care
Industry
Health Care Technology
Website
doximity.com

DOCS key statistics

Market cap
5.61B
Price-earnings ratio
37.00
Dividend yield
—
Average volume
3.10M
Volume
3.36M
Open price
$31.96
High today
$34.10
Low today
$31.82
52 Week high
$71.37
52 Week low
$17.15

Doximity (DOCS) at a glance

Doximity (DOCS) last traded at $33.35, with a market cap of 5.61B and a price-to-earnings ratio of 37.00.

Today the stock has traded between $31.82 and $34.10. The current price is 4.8% above the day's low and 2.2% below its high.

Volume so far is 3.36M shares, in line with the average of 3.10M shares a day.

Over the past year Doximity has ranged from $17.15 to $71.37, and now sits 30% of the way up that range.

Doximity met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q1 FY27 it reported $0.29 per share against an estimate of $0.3107.

The average analyst price target is $30.49, 8.6% below the current price, from 22 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

36%of 22 analyst ratings say Buy
  • Buy36.4%
  • Hold54.5%
  • Sell9.1%
Price target · 21 analystsAvg $30.49
Low
$18.18
Now
$33.35
High
$49.35

DOCS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 19.7% on average.

  1. Q2 FY25: reported $0.30 per share against an estimate of $0.2589
  2. Q3 FY25: reported $0.45 per share against an estimate of $0.3445
  3. Q4 FY25: reported $0.38 per share against an estimate of $0.278
  4. Q1 FY26: reported $0.36 per share against an estimate of $0.3063
  5. Q2 FY26: reported $0.45 per share against an estimate of $0.3866
  6. Q3 FY26: reported $0.46 per share against an estimate of $0.4545
  7. Q4 FY26: reported $0.26 per share against an estimate of $0.2888
  8. Q1 FY27: reported $0.29 per share against an estimate of $0.3107

DOCS news

  • Piero Cingari

    Health Care Stocks Hit Record Highs, GM Drops Nearly 8%: Stock Market Today

  • Press releaseBusiness Wire

    Doximity and Wolters Kluwer Sign Partnership to Bring UpToDate to Doximity Ask

  • Press releaseGlobe Newswire

    Robbins LLP Urges DOCS Stockholders to Contact the Firm for Information About the Class Action Against Doximity, Inc.

  • Press releaseNewsfile

    Kaplan Fox Notifies Investors of Doximity, Inc. (DOCS) of the Lead Plaintiff Deadline on November 16, 2026

  • Press releaseGlobe Newswire

    INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline, RGRD Law Announces - DOCS

  • Press releasePRNewswire

    DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline

  • Press releaseNewsfile

    Kaplan Fox Urges Doximity, Inc. (DOCS) Investors to Contact the Firm Before the Deadline on November 16, 2026

  • Press releaseBusiness Wire

    Doximity to Release Fiscal 2027 Second Quarter Results on November 5, 2026

Similar companies

Companies in the same industry as Doximity

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.